Are STDs More Common in Males or Females?

When all sexually transmitted infections are counted together, the total number of cases splits roughly evenly between men and women in the United States.¹ That aggregate figure, though, hides dramatic differences underneath. Some infections hit women far harder, others concentrate heavily in men, and the reasons stretch well beyond who is having sex with whom. Anatomy, hormones, screening patterns, and the vaginal microbiome all shift the odds in ways that make the question more interesting than a simple head count.

The Overall Numbers Hide Wildly Different Patterns

National estimates from 2018 put the total burden of prevalent and incident STIs at similar levels in U.S. men and women, but the similarity dissolves the moment you look at individual infections.¹ Chlamydia, for example, is reported at nearly double the rate in women compared to men. Gonorrhea and syphilis tilt the other direction, with higher reported rates in men.² Trichomoniasis is overwhelmingly a women’s disease in the data. And syphilis, especially in its primary and secondary stages, clusters so heavily in men that about 90% of reported cases are male, with the majority of those occurring in men who have sex with men.

So neither sex “wins” the overall count. The real story is which pathogen you are asking about, which population is being studied, and whether the numbers reflect true infection rates or just who gets tested.

Why Female Anatomy Increases Susceptibility

Women are disproportionately affected by STIs throughout their lives, and a large part of that comes down to urogenital anatomy.³ The vaginal canal and cervix offer a large surface area of thin, moist tissue that is more permeable to pathogens than the skin on the outside of the penis. During vaginal sex, semen pools against cervical tissue for an extended period, giving bacteria and viruses more time to establish infection.

One feature matters especially for younger women: cervical ectopy. This is a normal condition in which the inner lining of the cervix, made of a thin single-layered tissue, extends outward onto the cervical surface. That tissue is a weaker barrier than the thicker tissue it replaces, and it contains more of the immune cells that HIV targets.⁴ Cervical ectopy is more common in adolescents and in women using oral contraceptives, which helps explain why chlamydia rates are particularly high among women aged 15 to 24.⁵ Chlamydia specifically infects the columnar cells of the cervix, so exposing more of them to potential contact directly raises the odds of catching it.⁶

Men are not without anatomical vulnerabilities, but the keratinized skin of the penile shaft is a comparatively tough barrier. The foreskin, however, is a different matter, which is why circumcision changes the equation in measurable ways, as discussed further below.

Chlamydia and Trichomoniasis Skew Heavily Female

Chlamydia is the most commonly reported bacterial STI in many countries, and the sex gap in case counts is large. In the U.S., the rate of new chlamydial infections in women aged 15 to 39 is roughly double that in men of the same age range.⁵ Two factors overlap here. The first is the biological susceptibility from cervical ectopy described above. The second is a screening artifact: women get tested for chlamydia far more often than men, because routine screening is recommended for sexually active women under 25 but not for most men. Women who test positive get treated, recover, and then may be re-infected, each episode adding to the case count. Men with asymptomatic chlamydia, on the other hand, can carry the infection for months without ever being counted.

Trichomoniasis shows an even more lopsided pattern. Global estimates put the prevalence at about 5.3% in women versus 0.6% in men, and U.S. data from national health surveys found rates of 1.8% in women versus 0.5% in men.⁷ After adjusting for demographics and risk behaviors, women still had roughly five times the odds of being infected compared to men.⁸ A French study using molecular testing found that prevalence in men was ten times lower than in women.⁹

Since trichomoniasis is highly transmissible, you would expect men and women to carry it at roughly the same rate. The leading explanation is that the parasite spontaneously clears itself in many men without treatment, possibly because the male urethra is a less hospitable environment. Small studies have reported spontaneous resolution in somewhere between a third and two-thirds of male trichomoniasis cases.⁷ The organism simply does not survive as well in men, which means that at any given moment, far more women than men are walking around with an active infection.

Syphilis and Gonorrhea Skew Male

Syphilis stands at the opposite extreme. About 90% of primary and secondary syphilis cases in the United States occur in men, and among those, the majority are in men who have sex with men. The concentration is so extreme that syphilis surveillance is almost a different conversation from most other STIs. That said, congenital syphilis has been rising sharply in recent years, which means the consequences still land on women and their infants when syphilis circulates widely in a community. Gonorrhea reported rates are also higher in men than women in national surveillance data.²

Why the reversal? Part of it is network effects: sexual networks in which men who have sex with men have higher numbers of partners create dense transmission chains for infections that spread efficiently through anal sex. Part of it is biological: per-act transmission risk for receptive anal intercourse is higher than for vaginal intercourse. And part of it is the same screening bias working in reverse. Men presenting with urethral discharge from gonorrhea are symptomatic and get tested. Women with gonorrhea may have milder or no symptoms and go undetected, which paradoxically means their infections may be undercounted in surveillance data even as they continue spreading.

Herpes and HPV Tell Subtler Stories

Genital herpes caused by HSV-2 is consistently more common in women. In one U.S. primary care population, HSV-2 seroprevalence was 63% among Black women versus 40% among Black men, and 27% among white women versus 12% among white men.¹⁰ Women were roughly twice as likely as men of the same racial background to carry the virus. The receptive partner in vaginal sex is more exposed to viral shedding, and the mucosal tissue of the vagina and cervix is again the likely explanation for the asymmetry.

HPV is more nuanced. Men actually acquire new HPV infections at a higher rate than women in some studies, but they also clear the virus faster. A study in China found that men had about 1.5 times the incidence of oncogenic anal HPV compared to women, but at 12 months, none of the HPV 16/18 infections in men persisted while 44% of infections in women were still detectable.¹¹ This matters enormously because persistent HPV is what leads to cancer. So men catch HPV more often, but women bear the heavier disease burden because they are less able to shake it off, and persistent cervical HPV is the primary cause of cervical cancer.

HIV Transmission Is Not Equal in Both Directions

For HIV, the per-act risk of transmission during vaginal sex is roughly twice as high for the receptive partner (the woman, in heterosexual sex) as for the insertive partner. A systematic review estimated the per-act risk at about 8 per 10,000 exposures for receptive vaginal intercourse versus about 4 per 10,000 for insertive vaginal intercourse.¹² Those numbers are low per individual act, but they compound quickly with repeated exposure and are heavily influenced by factors like viral load, presence of other STIs, and circumcision status.

Globally, this biological asymmetry has combined with social and economic forces to shift the HIV epidemic increasingly toward women. In Sub-Saharan Africa, women and girls make up roughly 57% of all people living with HIV, and among young people aged 15 to 24 in the region, about 76% of those with HIV are female.¹³ Poverty, gender-based power imbalances, limited access to education, intimate partner violence, and lack of access to prevention services all funnel HIV risk disproportionately toward women in resource-limited settings.¹⁴

The Vaginal Microbiome as a Hidden Risk Multiplier

Bacterial vaginosis is not classified as an STI itself, but it reshapes the playing field for women’s STI risk in ways that have no male equivalent. BV disrupts the normal community of protective bacteria in the vagina, and women with BV have a significantly higher rate of STI co-infections. In one study, 28% of women with BV had a concurrent STI versus about 20% of women without, and the gap was even wider for co-infections involving two or more STI-causing organisms.¹⁵

The relationship holds up when looking at future infections, not just co-existing ones. In a South African cohort, women with BV at baseline had higher rates of new trichomoniasis and chlamydia infections over time, and BV remained a significant predictor of trichomoniasis even after adjusting for age and marital status.¹⁶ Another analysis found that women with the most severely disrupted vaginal flora had about 2.7 times the risk of acquiring an STI compared to women with normal flora.¹⁷

BV is extremely common, affecting somewhere around a quarter to a third of women of reproductive age in many populations. It often recurs after treatment. This means a substantial portion of women are walking around with a vaginal environment that makes them more vulnerable to STIs, a risk amplifier that has no direct parallel in male biology.

Circumcision and Male-Specific Protection

Male circumcision is one of the few anatomical factors that reduces STI risk for men specifically. The inner foreskin has a thinner mucosal surface with a high density of immune target cells. Removing it eliminates that entry point. Studies show that circumcision reduces a man’s risk of acquiring HIV by about 50 to 60% over time and cuts the risk of catching herpes and HPV by around 30%.¹⁸

These findings come primarily from studies of heterosexual men in high-prevalence settings, particularly in Sub-Saharan Africa. Among men who have sex with men, the evidence is more mixed. A large meta-analysis found that circumcision was associated with roughly 23% lower odds of HIV infection in MSM overall, but the protection was concentrated in low- and middle-income countries and not significant in high-income settings.¹⁹ Circumcision was also associated with reduced odds of herpes and penile HPV among HIV-positive MSM. The effect makes biological sense, since the insertive partner’s foreskin is the relevant tissue, but the degree of protection depends on the type of sexual contact and the setting.

Screening Bias Warps the Numbers

Surveillance data are only as good as the testing that generates them, and testing is not applied equally to men and women. For some infections, women get tested more. Routine chlamydia screening is recommended for all sexually active women under 25 in the U.S. but not for most men, which inflates the apparent female-to-male ratio of reported chlamydia. For other infections, men get tested more. One emergency department study found that nearly half of men diagnosed with an STI were screened for syphilis, compared to only about 7% of women with the same diagnosis.²⁰

There are also gaps in how thoroughly testing is done. Most STI testing in women is limited to genital specimens, but infections can also occur in the throat and rectum. Survey data show that about a third of women engage in anal sex and over 75% engage in oral sex, yet multi-site testing is rarely performed.²¹ Previous analyses have estimated that adding extragenital testing in women could increase STI detection by 6 to 50% compared to urogenital testing alone. That same study also found that women diagnosed with an STI were less likely than men to be tested for HIV or offered pre-exposure prophylaxis, a striking gap given that an existing STI raises HIV risk.

All of this means that the reported sex ratios for different STIs are not clean measurements of biology. They are a mixture of true biological differences, behavioral patterns, and deeply uneven testing practices.

Women Bear a Heavier Burden of Consequences

Even when infection rates are comparable, the downstream damage is not. Many STIs cause few or no symptoms in women initially, which means they go untreated longer. Untreated chlamydia or gonorrhea can ascend into the uterus and fallopian tubes, causing pelvic inflammatory disease. Women who have had PID face roughly ten times the risk of ectopic pregnancy, and infertility after PID ranges from about 6% to 60% depending on the severity and number of infections.²² Men with untreated chlamydia or gonorrhea can develop epididymitis and, in theory, fertility problems, but the frequency is far lower and the path to serious harm is generally shorter.

Pregnancy adds another dimension. STIs that would otherwise be manageable in a non-pregnant person can have devastating effects on a developing fetus. Syphilis transmitted during pregnancy can cause stillbirth, bone deformities, and neurological damage. Gonorrhea and chlamydia can infect the newborn’s eyes during delivery. Herpes acquired near the time of delivery can cause life-threatening neonatal infection. HIV can be transmitted during pregnancy, labor, or breastfeeding. The entire category of “vertical transmission” is a risk that falls exclusively on women and their infants, adding a layer of consequence that has no counterpart in male infection.

Hormonal Cycling and Immune Windows

The female reproductive tract does not maintain a constant level of immune defense throughout the menstrual cycle. Estrogen and progesterone modulate how aggressively the immune system responds to pathogens in the cervix and uterus. During the luteal phase, when the body is preparing for a possible pregnancy, immune surveillance in the upper reproductive tract dials down to avoid rejecting a fertilized egg. This creates a periodic window of relative vulnerability to infection that has no male analog.¹³

Hormonal contraceptives can also influence susceptibility. Some research has linked certain progestin-based contraceptives to changes in cervical mucus and immune cell populations that may affect STI risk, though the evidence is inconsistent enough that public health authorities have not issued contraceptive-specific STI warnings. What is well-established is that oral contraceptives increase the prevalence of cervical ectopy, which circles back to the vulnerability described earlier in this article. The interplay between reproductive hormones and STI susceptibility is an area where the science is still being actively sorted out, but the direction of the effect consistently points toward increased risk for women during specific hormonal states.

Social and Economic Forces That Amplify Biological Differences

Biology does not operate in a vacuum, and the global pattern of STIs in women cannot be explained by anatomy alone. Economic dependence, power imbalances in relationships, and limited access to health services all compound the biological vulnerability. Women in many parts of the world have less ability to negotiate condom use, less access to STI prevention information, and less autonomy over when and with whom they have sex. Intimate partner violence, which disproportionately affects women, is directly linked to higher STI rates both through forced unprotected sex and through the erosion of a person’s ability to seek testing and treatment.¹⁴

Migration driven by economic hardship also plays a role. When men migrate for work and women are left without income or resources, transactional sex can become a survival strategy, with STI risk as a foreseeable consequence. These structural factors are not peripheral. In the regions of the world where STI burdens are highest, they are often the dominant drivers, dwarfing the contribution of biological susceptibility alone. Addressing them requires interventions that go well beyond clinical medicine, including education access, economic support, and legal protections against gender-based violence.

1
PubMed Central. Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2018
2
PubMed Central. Gender Differences in Bacterial STIs in Canada
3
PubMed Central. Sexually transmitted infections and female reproductive health
4
PubMed Central. Cervical ectopy: associations with sexually transmitted infections and HIV
5
PubMed Central. Estimates of the Prevalence and Incidence of Chlamydia and Gonorrhea Among US Men and Women, 2018
6
PubMed. Relationship of cervical ectopy to chlamydia infection in young women
7
PubMed Central. Trichomoniasis
8
PLoS ONE. Prevalence and risk factors for Trichomonas vaginalis infection among adults in the U.S., 2013–2014
9
PubMed. Prevalence and bio-clinical characterisation of Trichomonas vaginalis infection in a large cohort of French patients screened using a molecular syndromic panel for sexually transmitted infections
10
PubMed. Genital herpes in a primary care clinic. Demographic and sexual correlates of herpes simplex type 2 infections
11
PubMed. Sex differences in the incidence and clearance of anal human papillomavirus infection among heterosexual men and women in Liuzhou, China
12
PubMed Central. Estimating per-act HIV transmission risk: a systematic review
13
PubMed Central. Regulation of Mucosal Immunity in the Female Reproductive Tract: The Role of Sex Hormones in Immune Protection Against Sexually Transmitted Pathogens
14
PubMed Central. Poverty, gender inequities, and women’s risk of human immunodeficiency virus/AIDS
15
PubMed Central. Relationship between Bacterial Vaginosis and Sexually Transmitted Infections: Coincidence, Consequence or Co-Transmission?
16
PubMed. Prevalent bacterial vaginosis infection – a risk factor for incident sexually transmitted infections in women in Durban, South Africa
17
PubMed Central. Severity of Bacterial Vaginosis and the Risk of Sexually Transmitted Infection
18
PubMed Central. Male circumcision and Sexually transmitted Infections – An update
19
The Lancet. Association between male circumcision and HIV and other sexually transmitted infections among men who have sex with men
20
PubMed. Gender differences in testing for syphilis in emergency department patients diagnosed with sexually transmitted diseases
21
PubMed Central. Women Are Less Likely to Be Tested for HIV or Offered Prep at Time of STI Diagnosis
22
American Journal of Obstetrics and Gynecology. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries